WICKER, HYDE-SMITH & COLLEAGUES PLEDGE TO BLOCK ANY IRAN DEAL NOT SUBMITTED TO CONGRESS FOR APPROVAL 

WICKER, HYDE-SMITH & COLLEAGUES PLEDGE TO BLOCK ANY IRAN DEAL NOT SUBMITTED TO CONGRESS FOR APPROVAL 

Miss. Senators Admonish Biden Administration Over Nuclear Talks 

WASHINGTON, D.C. – U.S. Senators Roger Wicker (R-Miss.) and Cindy Hyde-Smith (R-Miss.) on Tuesday joined colleagues in a letter to President Biden rebuking the administration’s negotiations for a new Iran nuclear deal.

The letter comes as reports emerge that the Biden administration is actively renegotiating another entry into...

HYDE-SMITH SAYS ADMINISTRATION ‘SLOW WALKING’ OFFSHORE ENERGY, IMPERILING PRODUCTION OUTLOOK

HYDE-SMITH SAYS ADMINISTRATION ‘SLOW WALKING’ OFFSHORE ENERGY, IMPERILING PRODUCTION OUTLOOK

‘I Have Never Seen Such Slow Walking in My Life, to the Detriment of My State of Mississippi,’ Miss. Senator Declares

020822 ENR Nom Hearing - Offshore 1
VIDEO:  Senator Hyde-Smith Questions Nominee on Biden Energy Policies.

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today accused the Biden administration of continuing to slow walk the permitting and lease sales for offshore energy production, to the detriment of...

HYDE-SMITH WELCOMES FDA APPROVAL OF FIRST GENERIC OF RESTASIS

HYDE-SMITH WELCOMES FDA APPROVAL OF FIRST GENERIC OF RESTASIS

Miss. Senator Long Critical of Company behind Skyrocketing Cost of Prescription Eye-Drop Medication

drug pricing speech

WATCH IT AGAIN:  In 2020, Hyde-Smith Cited Hard-hit Mississippians to Push for Prescription Drug Pricing Relief

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today welcomed approval by the Food and Drug Administration (FDA) of a generic alternative to the eye-drop prescription drug Restasis, a decision she has long...